Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
T cell antigen targets are molecules, typically proteins or peptides, expressed on the surface of cells that can be recognized by T cell receptors (TCRs) or engineered receptors such as chimeric antigen receptors (CARs). These antigens are crucial for directing T cell-mediated immune responses, especially in cancer immunotherapy, where they enable the immune system to distinguish and attack malignant cells. They include tumor-associated antigens (TAAs), tumor-specific antigens/neoantigens, and viral-derived antigens. Targeting these antigens is key for adoptive cell therapies like CAR-T and TCR-T cell therapies.
T cell receptor (TCR) or chimeric antigen receptor (CAR) binding, T cell activation, target cell lysis
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on T Cell Antigen Targets (T Cell Ag Targets).